Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8669281 Prodrugs of fumarates and their use in treating various diseases

Patent 8669281 was granted and assigned to Alkermes (company) on March, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Alkermes (company)

Current Assignee

Alkermes (company)

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8669281

Date of Patent

March 11, 2014

Patent Application Number

14032736

Date Filed

September 20, 2013

Patent Citations Received

‌

US Patent 11903918 Fumarate ester dosage forms with enhanced gastrointestinal tolerability

‌

US Patent 12076306 Prodrugs of fumarates and their use in treating various diseases

‌

US Patent 11938111 Pharmaceutical compositions of dimethyl fumarate

‌

US Patent 11672783 Pharmaceutical combination comprising a selective S1P1 receptor agonist

‌

US Patent 11679092 Prodrugs of fumarates and their use in treating various diseases

‌

US Patent 11905298 Prodrugs of fumarates and their use in treating various diseases

Patent Primary Examiner

‌

Sarah Pihonak

Patent abstract

The present invention provides compounds of formula (I),

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8669281 Prodrugs of fumarates and their use in treating various diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API